Annual long term liabilities:
$2.21B-$1.04B(-31.95%)Summary
- As of today (September 17, 2025), TAK annual total long term liabilities is $2.21 billion, with the most recent change of -$1.04 billion (-31.95%) on March 1, 2025.
- During the last 3 years, TAK annual long term liabilities has fallen by -$4.35 billion (-66.29%).
- TAK annual long term liabilities is now -80.54% below its all-time high of $11.36 billion, reached on March 31, 2019.
Performance
TAK Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$5.77B+$3.56B(+161.13%)Summary
- As of today (September 17, 2025), TAK quarterly total long term liabilities is $5.77 billion, with the most recent change of +$3.56 billion (+161.13%) on June 1, 2025.
- Over the past year, TAK quarterly long term liabilities has increased by +$48.13 million (+0.84%).
- TAK quarterly long term liabilities is now -59.54% below its all-time high of $14.27 billion, reached on June 30, 2019.
Performance
TAK quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TAK Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | +0.8% |
| 3 y3 years | -66.3% | -37.8% |
| 5 y5 years | -78.0% | -55.4% |
TAK Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.3% | at low | -37.8% | +161.1% |
| 5 y | 5-year | -78.0% | at low | -56.7% | +161.1% |
| alltime | all time | -80.5% | +342.2% | -59.5% | +513.7% |
TAK Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $5.77B(+161.1%) |
| Mar 2025 | $2.21B(-32.0%) | $2.21B(-60.7%) |
| Dec 2024 | - | $5.63B(-3.8%) |
| Sep 2024 | - | $5.85B(+2.2%) |
| Jun 2024 | - | $5.73B(+76.2%) |
| Mar 2024 | $3.25B(-34.3%) | $3.25B(-49.3%) |
| Dec 2023 | - | $6.41B(-7.0%) |
| Sep 2023 | - | $6.89B(-4.1%) |
| Jun 2023 | - | $7.19B(+45.3%) |
| Mar 2023 | $4.95B(-24.5%) | $4.95B(-44.5%) |
| Dec 2022 | - | $8.92B(-1.9%) |
| Sep 2022 | - | $9.09B(-2.1%) |
| Jun 2022 | - | $9.28B(+41.5%) |
| Mar 2022 | $6.56B(-24.7%) | $6.56B(-43.0%) |
| Dec 2021 | - | $11.51B(-1.3%) |
| Sep 2021 | - | $11.66B(-2.7%) |
| Jun 2021 | - | $11.99B(+37.6%) |
| Mar 2021 | $8.71B(-13.2%) | $8.71B(-34.6%) |
| Dec 2020 | - | $13.32B(-0.1%) |
| Sep 2020 | - | $13.33B(+3.0%) |
| Jun 2020 | - | $12.95B(+29.1%) |
| Mar 2020 | $10.03B(-11.7%) | $10.03B(-23.1%) |
| Dec 2019 | - | $13.05B(-7.4%) |
| Sep 2019 | - | $14.09B(-1.3%) |
| Jun 2019 | - | $14.27B(+25.6%) |
| Mar 2019 | $11.36B(+283.8%) | $11.36B(+193.4%) |
| Dec 2018 | - | $3.87B(+16.1%) |
| Sep 2018 | - | $3.34B(+1.0%) |
| Jun 2018 | - | $3.30B(+11.5%) |
| Mar 2018 | $2.96B(-14.1%) | $2.96B(-16.6%) |
| Dec 2017 | - | $3.55B(-8.0%) |
| Sep 2017 | - | $3.86B(+1.2%) |
| Jun 2017 | - | $3.81B(+10.6%) |
| Mar 2017 | $3.45B(+6.1%) | $3.45B(+0.6%) |
| Dec 2016 | - | $3.43B(-7.3%) |
| Sep 2016 | - | $3.69B(-1.6%) |
| Jun 2016 | - | $3.75B(+15.5%) |
| Mar 2016 | $3.25B(-8.9%) | $3.25B(+1.2%) |
| Dec 2015 | - | $3.21B(-7.7%) |
| Sep 2015 | - | $3.48B(-4.4%) |
| Jun 2015 | - | $3.64B(+2.0%) |
| Mar 2015 | $3.57B(-27.5%) | $3.57B(-16.4%) |
| Dec 2014 | - | $4.27B(-14.4%) |
| Sep 2014 | - | $4.99B(+16.7%) |
| Jun 2014 | - | $4.27B(-20.3%) |
| Mar 2014 | $4.92B(-8.9%) | $5.36B(-6.3%) |
| Dec 2013 | - | $5.72B(-1.3%) |
| Sep 2013 | - | $5.80B(+0.4%) |
| Jun 2013 | - | $5.77B(-3.5%) |
| Mar 2013 | $5.40B | $5.98B(-5.6%) |
| Dec 2012 | - | $6.34B(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $6.20B(+1.0%) |
| Jun 2012 | - | $6.14B(+16.0%) |
| Mar 2012 | $5.29B(+122.9%) | $5.29B(-2.9%) |
| Dec 2011 | - | $5.45B(-3.8%) |
| Sep 2011 | - | $5.67B(+120.4%) |
| Jun 2011 | - | $2.57B(+8.3%) |
| Mar 2011 | $2.37B(+6.7%) | $2.37B(-9.4%) |
| Dec 2010 | - | $2.62B(-0.4%) |
| Sep 2010 | - | $2.63B(+0.6%) |
| Jun 2010 | - | $2.61B(+6.3%) |
| Mar 2010 | $2.23B(+7.0%) | $2.46B(+3.9%) |
| Dec 2009 | - | $2.37B(-3.8%) |
| Sep 2009 | - | $2.46B(+0.5%) |
| Jun 2009 | - | $2.45B(+3.5%) |
| Mar 2009 | $2.08B(+124.0%) | $2.37B(-5.0%) |
| Dec 2008 | - | $2.49B(-9.2%) |
| Sep 2008 | - | $2.74B(-9.5%) |
| Jun 2008 | - | $3.03B(+222.2%) |
| Mar 2008 | $928.17M(-26.1%) | - |
| Mar 2008 | - | $940.72M(-24.6%) |
| Dec 2007 | - | $1.25B(-1.2%) |
| Sep 2007 | - | $1.26B(-6.4%) |
| Jun 2007 | - | $1.35B(+5.9%) |
| Mar 2007 | $1.26B(+4.1%) | - |
| Mar 2007 | - | $1.27B(-4.4%) |
| Dec 2006 | - | $1.33B(+7.5%) |
| Sep 2006 | - | $1.24B(-7.5%) |
| Jun 2006 | - | $1.34B(+8.4%) |
| Mar 2006 | $1.21B(+0.7%) | - |
| Mar 2006 | - | $1.24B(-9.3%) |
| Dec 2005 | - | $1.36B(+15.8%) |
| Sep 2005 | - | $1.18B(+13.2%) |
| Jun 2005 | - | $1.04B(-8.3%) |
| Mar 2005 | $1.20B(-9.0%) | - |
| Mar 2005 | - | $1.13B(-12.8%) |
| Dec 2004 | - | $1.30B(+9.2%) |
| Sep 2004 | - | $1.19B(-7.3%) |
| Jun 2004 | - | $1.28B |
| Mar 2004 | $1.32B(+53.8%) | - |
| Mar 2003 | $855.73M(-11.5%) | - |
| Mar 2002 | $966.59M(-14.1%) | - |
| Mar 2001 | $1.13B(+77.6%) | - |
| Mar 2000 | $633.64M(-26.3%) | - |
| Mar 1999 | $859.99M(+72.0%) | - |
| Mar 1998 | $500.05M(-41.3%) | - |
| Mar 1997 | $851.16M(+33.2%) | - |
| Mar 1996 | $639.02M(-50.6%) | - |
| Mar 1995 | $1.29B(+22.8%) | - |
| Mar 1994 | $1.05B(-12.1%) | - |
| Mar 1993 | $1.20B(+50.0%) | - |
| Mar 1992 | $798.96M(-27.6%) | - |
| Mar 1991 | $1.10B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total long term liabilities?
- What is the all time high annual long term liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual long term liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly long term liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total long term liabilities?
The current annual long term liabilities of TAK is $2.21B
What is the all time high annual long term liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total long term liabilities is $11.36B
What is Takeda Pharmaceutical Company Limited annual long term liabilities year-on-year change?
Over the past year, TAK annual total long term liabilities has changed by -$1.04B (-31.95%)
What is Takeda Pharmaceutical Company Limited quarterly total long term liabilities?
The current quarterly long term liabilities of TAK is $5.77B
What is the all time high quarterly long term liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total long term liabilities is $14.27B
What is Takeda Pharmaceutical Company Limited quarterly long term liabilities year-on-year change?
Over the past year, TAK quarterly total long term liabilities has changed by +$48.13M (+0.84%)